Ingrasys

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

The tech platform said producers can better detect contamination and allergens with its program in order to achieve compliance.

DUBAI, AE / ACCESS Newswire / March 14, 2025 / As financial markets become increasingly unpredictable, investors are seeking more reliable, data-driven solutions to manage risk and optimize decision-making.

Intuitive Surgical is investing heavily in AI, AR, leading to future profitability. Learn why ISRG stock may present a buying opportunity.

Backed by Bain Capital Ventures, Grain Optimizes FX for B2B Transactions to Address Growing Complexity and Risk in Global Trade TEL AVIV, IL /

Beyond speed, AI has also helped reduce costs. Conventional methods required nearly $35,000 per genome analysis, but AI-driven models running on GPUs have lowered the cost to under $2,000, making high-quality genomic research more accessible.

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.

The integration will focus on secure payment APIs, real-time risk assessments, fraud prevention, and automated API management.